SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : EXTI - only public co. developing liver device
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Danny Kim who wrote (153)1/13/1998 11:07:00 PM
From: MaxLeverage  Read Replies (1) of 1063
 
"We expect funding for Xenogenics early 1998, and are
finalizing our agreements with Loyola in the near future so that we can commence our clinical trials."

Well. Things seem to be in place.These two gentlemen are the directors of Loyola's Liver Transplantation program

Medical Director, Liver Transplantation - David Van Thiel, M.D.
Surgical Director, Liver Transplantation - John Brems, M.D.
lumc.edu

Here's a relatively new bio of John J. Brems, M.D., F.A.C.S. Take a look at the "Research Initiatives" at the bottom of the page.
meddean.luc.edu

Can funding be near?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News